Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Tacke

Showing results (41-50 of 862) with videos related to

Pageof 87
Sort By:
Hepatology (Baltimore, Md.)|March 12, 2022
Many roads lead to Rome: The FGF4-AMP-activated protein kinase-Caspase 6 signal axis in NAFLD and NASHAlena Laschtowitz, Frank Tacke
Nature Reviews. Gastroenterology & Hepatology|March 15, 2022
Location, location, location - spatial insight into hepatic macrophage populationsAdrien Guillot, Frank Tacke
Expert Review of Gastroenterology & Hepatology|December 14, 2011
Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniquesFrank Tacke, Ralf Weiskirchen
Liver International : Official Journal of the International Association for the Study of the Liver|November 29, 2019
How effective and how durable is DAA-therapy in HCV-infected drug users?Patrick Ingiliz, Frank Tacke
Cells|January 6, 2019
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and DiseaseRalf Weiskirchen, Frank Tacke
Cellular and Molecular Gastroenterology and Hepatology|July 18, 2024
Oxidized HMGB1 Adducts Unleash Inflammation in Alcohol-Associated Liver DiseasePavitra Kumar, Frank Tacke
Alimentary Pharmacology & Therapeutics|December 21, 2025
Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End-Stage Liver DiseaseIgor Spivak, Frank Tacke
Critical Care (London, England)|December 21, 2011
Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICUAlexander Koch, Frank Tacke
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2017
A not so easy genotype-striking regional differences in SOF/RBV treatment responses in HCV GT2Frank Tacke, Stefan Mauss
Hepatic Medicine : Evidence and Research|September 28, 2020
Identifying High-Risk NASH Patients: What We Know so FarMarten Schulz, Frank Tacke
Pageof 87

Showing results (41-50 of 862) with videos related to

Sort By:
Pageof 87
Hepatology (Baltimore, Md.)|March 12, 2022
Many roads lead to Rome: The FGF4-AMP-activated protein kinase-Caspase 6 signal axis in NAFLD and NASHAlena Laschtowitz, Frank Tacke
Nature Reviews. Gastroenterology & Hepatology|March 15, 2022
Location, location, location - spatial insight into hepatic macrophage populationsAdrien Guillot, Frank Tacke
Expert Review of Gastroenterology & Hepatology|December 14, 2011
Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniquesFrank Tacke, Ralf Weiskirchen
Liver International : Official Journal of the International Association for the Study of the Liver|November 29, 2019
How effective and how durable is DAA-therapy in HCV-infected drug users?Patrick Ingiliz, Frank Tacke
Cells|January 6, 2019
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and DiseaseRalf Weiskirchen, Frank Tacke
Cellular and Molecular Gastroenterology and Hepatology|July 18, 2024
Oxidized HMGB1 Adducts Unleash Inflammation in Alcohol-Associated Liver DiseasePavitra Kumar, Frank Tacke
Alimentary Pharmacology & Therapeutics|December 21, 2025
Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End-Stage Liver DiseaseIgor Spivak, Frank Tacke
Critical Care (London, England)|December 21, 2011
Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICUAlexander Koch, Frank Tacke
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2017
A not so easy genotype-striking regional differences in SOF/RBV treatment responses in HCV GT2Frank Tacke, Stefan Mauss
Hepatic Medicine : Evidence and Research|September 28, 2020
Identifying High-Risk NASH Patients: What We Know so FarMarten Schulz, Frank Tacke
Pageof 87